Gilead Sciences Profile News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Schroder Investment Management Group raised its position in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 8.8% in the fourth quarter, Holdings Channel reports. The fund owned 1,646,589 shares of the biopharmaceutical company’s stock after buying an additional 132,679 shares during the period. Schroder Investment Management Group’s holdings in Gilead Sciences were worth $133,390,000 as […]

CWA Asset Management Group LLC reduced its holdings in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 3.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 13,971 shares of the biopharmaceutical company’s stock after selling 433 shares during the period. CWA Asset Management Group […]

CWA Asset Management Group LLC reduced its holdings in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 3.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 13,971 shares of the biopharmaceutical company’s stock after selling 433 shares during the period. CWA Asset Management Group […]

Premier Fund Managers Ltd lessened its stake in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 7.5% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 9,864 shares of the biopharmaceutical company’s stock after selling 800 shares during the quarter. Premier Fund Managers Ltd’s holdings in Gilead Sciences […]

CIBC Asset Management Inc trimmed its position in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 0.7% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 443,459 shares of the biopharmaceutical company’s stock after selling 3,137 shares during the period. CIBC […]